Prof. Shailendra Kumar Verma

Defence Research & Development Establishment, India

Email: skvdrde@yahoo.co.in

Qualifications

2009  Ph.D., Dr BR Ambedker University, India

2001  M.S., Dr BR Ambedker University, India

1997  B.S., Dr BR Ambedker University, India

Publications (Selected)

1. Verma SK, Jain S, Kumar S. Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice.  World J Microbiol Biotechnol. 2012, 28:2487–2495.
2. Petrosyan A, Ali MF, Verma SK, Cheng H, Cheng PW. Non-muscle myosin IIA transports a Golgi glycosyltransferase to the endoplasmic reticulum by binding to its cytoplasmic tail. Int J Biochem Cell Biol. 2012, 44(7):1153-65.
3. Kumar S, Malik P, Verma SK, Pal V, Gautam V, Mukhopadhyay C, Rai GP. Use of a recombinant burkholderia intracellular motility a protein for immunodiagnosis of glanders. Clin Vaccine Immunol. 2011, 18(9):1456-61.
4. Kumar S, Kapil S, Gautam V, Verma SK, Ray P. Peptides representing the specific variable regions but not the full porin proteins can be useful for antibody based diagnosis of typhoid fever. Folia Microbiol. 2010, 55(5):520- 7.
5. Verma SK, Kumar S, Gupta N, Vedi S, Bhattacharya SM, Rao PVL. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice. Vaccine 2009, 27(49):6905-9.
6. Verma SK, Gupta N, Pattnaik P, Babu JP, Rao PVL, Kumar S. Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to porcine stable kidney cells. Protein Pept Lett. 2009, 16(11):1334-1341.
7. Verma SK, Gautam V, Balakrishna K, Kumar S. Over expression, Purification and Immunogenicity of Recombinant Porin Proteins of Salmonella enterica serovar Typhi (S. Typhi). J. Microbiol. Biotech. 2009, 19(9): 1034–1040.
8. Verma SK, Bansal I, Vedi S, Saxena JK, Katoch VM, Bhattacharya SM. Molecular cloning, purification and characterization of myosin of human lymphatic filarial parasite Brugia malayi. Parasitol. Res. 2008, 102(3):481-9.
9. Pattnaik P, Babu JP, Verma SK, Tak V, Rao PV. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate. J Chromatogr B.  2007, 846(1-2):184-94.
10. Dash PK, Parida MM, Santhosh SR, Verma SK, Tripathi NK, Ambuj S, Saxena P, Gupta N, Chaudhary M, Babu JP, Lakshmi V, Mamidi N, Subhalaxmi MV, Lakshmana Rao PV, Sekhar K. East Central South African genotype as the causative agent in reemergence of Chikungunya outbreak in India. Vector Borne Zoonotic Dis. 2007, 7(4):519-27.
11. Parida M, Dash PK, Tripathi NK, Ambuj, Sannarangaiah S, Saxena P, Agarwal S, Sahni AK, Singh SP, Rathi AK, Bhargava R, Abhyankar A, Verma SK, Rao PV, Sekhar K. Japanese Encephalitis Outbreak, India, 2005. Emerg Infect Dis. 2006, 12(9):1427-30.
12. Parida MM, Tripathi NK, Ambuj, Saxena P., Santhosh SR, Dash PK, Agarwal S, Sahni AK, Bhargava R, Abhyankar A, Verma SK, Rao PVL, Sekhar K. Japanese Encephalitis Virus as the etiology of viral encephalitis outbreak in Gorakhpur, India 2005. Rapid Response in British Medical Journal (18 February 2006).
13. Bajpai P, Verma SK, Katiyar D, Tewari N, Tripathi RP, Bansal I, Saxena JK, Bhattacharya SM. Search of new prototypes for chemotherapy of filariasis: Chemotherapeutic and biochemical approach. Parasitol. Res. 2005, 95 (6) 383-390.